Partner Content Partner Content Registration opens for SMi’s leading Pain Therapeutics Confe... Registration opens for Pain Therapeutics
News Pain Therapeutics' opioid drug fails to gain FDA approval The US regulator has rejected Pain Therapeutics' abuse-deterrent opioid painkiller drug, Remoxy, for the fourth time.
Partner Content Partner Content Pain Therapeutics conference is taking place in London next ... SMi Group reports: To reserve last available seats at the Pain Therapeutics Conference, head on to the event website http://www.pain-therap
Partner Content Partner Content Great time for pain research: exclusive interviews with indu... SMi Group reports: Ahead of 18th annual Pain Therapeutics Conference (London, 21 - 22 May) SMi Group have caught up with Neil S
Partner Content Partner Content Explore innovative approaches and novel targets in analgesic... The opioid crisis has cost the economy $1 trillion since 2001 in the USA alone, and the prospect does not look like it will get better any time soon.
News Neurogene drops high-dose arm in Rett study after death The patient affected by a serious adverse event in Neurogene's clinical trial of Rett syndrome gene therapy has now died
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
